These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 9005813
1. The role of (Z)-2,3-didehydrophenylalanine and phenylalanine C-terminal residues in determining the chemotactic activity of formylpeptides. Torrini I, Zecchini GP, Paradisi MP, Spisani S. Arch Pharm (Weinheim); 1996 Mar; 329(3):143-8. PubMed ID: 9005813 [Abstract] [Full Text] [Related]
2. Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe. Pagani Zecchini G, Torrini I, Paglialunga Paradisi M, Lucente G, Spisani S. Farmaco; 1994 Nov; 40(11):739-42. PubMed ID: 7832975 [Abstract] [Full Text] [Related]
3. Modified chemotactic peptides: synthesis, conformation, and biological activity of For-Thp-Leu-delta ZPhe-OMe. Torrini I, Zecchini GP, Paglialunga Paradisi M, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Traniello S, Spisani S, Cerichelli G. Biopolymers; 1994 Oct; 34(10):1291-302. PubMed ID: 7948717 [Abstract] [Full Text] [Related]
4. Pseudopeptides containing the 2-hydrazonoacyl fragment: analogs of the chemotactic agent HCO-Met-Leu-Phe-OMe. Torrini I, Nalli M, Paglialunga Paradisi M, Pagani Zecchini G, Lucente G, Spisani S. J Pept Res; 2001 Jul; 58(1):56-66. PubMed ID: 11454170 [Abstract] [Full Text] [Related]
5. The effect of the cyclopropyl group on the conformation of chemotactic formyl tripeptides. Headley AD, Ganesan R, Nam J. Bioorg Chem; 2003 Apr; 31(2):99-108. PubMed ID: 12729567 [Abstract] [Full Text] [Related]
6. Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs. Pagani Zecchini G, Nalli M, Mollica A, Lucente G, Paglialunga Paradisi M, Spisani S. J Pept Res; 2002 Jun; 59(6):283-91. PubMed ID: 12010519 [Abstract] [Full Text] [Related]
7. Synthesis and activity on human neutrophil functions of fMLF-OMe analogs containing alkyl spacers at the central position. Pagani Zecchini G, Morera E, Nalli M, Paglialunga Paradisi M, Lucente G, Spisani S. Farmaco; 2001 Nov; 56(11):851-8. PubMed ID: 11765037 [Abstract] [Full Text] [Related]
8. Modified chemotactic peptides: synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe. Torrini I, Pagani Zecchini G, Paglialunga Paradisi M, Lucente G, Mastropietro G, Gavuzzo E, Mazza F, Pochetti G, Traniello S, Spisani S. Biopolymers; 1996 Sep; 39(3):327-37. PubMed ID: 8756513 [Abstract] [Full Text] [Related]
9. Formyl peptide chemoattractants. Synthesis and chemotactic activity. Falcomer C, Vertuani G, Boggian M, Scatturin A, Spisani S, Cavalletti T, Traniello S. Farmaco Sci; 1987 Nov; 42(11):815-22. PubMed ID: 3443176 [Abstract] [Full Text] [Related]
12. An evaluation of fMLP pocket dimensions and features using formyltetrapeptides. Cavicchioni G, Varani K, Niccoli S, Rizzuti O, Spisani S. J Pept Res; 1999 Oct; 54(4):336-43. PubMed ID: 10532239 [Abstract] [Full Text] [Related]
13. New fMLF-OMe analogues containing constrained mimics of phenylalanine residue. Torrini I, Mastropietro G, Pagani Zecchini G, Paglialunga Paradisi M, Lucente G, Spisani S. Arch Pharm (Weinheim); 1998 May; 331(5):170-6. PubMed ID: 9691248 [Abstract] [Full Text] [Related]
14. Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe. Torrini I, Pagani Zecchini G, Paglialunga Paradisi M, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Traniello S, Spisani S. Biopolymers; 1994 Jan; 34(1):1-9. PubMed ID: 8110962 [Abstract] [Full Text] [Related]
15. Biological activity in human neutrophils of di-tripeptides, analogues of the chemotactic fMLP. Cavicchioni G, Turchetti M, Spisani S. Bioorg Med Chem Lett; 2001 Dec 17; 11(24):3157-9. PubMed ID: 11720864 [Abstract] [Full Text] [Related]
16. Chemotactic peptide analogues. Synthesis and chemotactic activity of N-formyl-Met-Leu-Phe analogues containing (S)-phenylalaninol derivatives. Zecchini GP, Paradisi MP, Torrini I, Spisani S. Arch Pharm (Weinheim); 1995 Sep 17; 328(9):673-6. PubMed ID: 7487425 [Abstract] [Full Text] [Related]
17. [Acylated tripeptides as chemotaxin antagonists (author's transl)]. Opitz W, Fruchtmann R. Hoppe Seylers Z Physiol Chem; 1981 Aug 17; 362(8):1037-41. PubMed ID: 7346374 [Abstract] [Full Text] [Related]
18. Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues. Mollica A, Feliciani F, Stefanucci A, Costante R, Lucente G, Pinnen F, Notaristefano D, Spisani S. J Pept Sci; 2012 Jun 17; 18(6):418-26. PubMed ID: 22528501 [Abstract] [Full Text] [Related]
19. Hybrid alpha/beta3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe. Giordano C, Lucente G, Mollica A, Nalli M, Pagani Zecchini G, Paglialunga Paradisi M, Gavuzzo E, Mazza F, Spisani S. J Pept Sci; 2004 Aug 17; 10(8):510-23. PubMed ID: 15347138 [Abstract] [Full Text] [Related]
20. Synthesis, biological activity, conformational analysis by NMR and molecular modeling of N-formyl-L-Met-L-Pro-L-Phe-OMe, a proline analogue of the chemotactic peptide N-formyl-L-Met-L-Leu-L-Phe-OH. Dugas H, Laroche M, Ptak M, Labbé H. Int J Pept Protein Res; 1993 Jun 17; 41(6):595-605. PubMed ID: 8394292 [Abstract] [Full Text] [Related] Page: [Next] [New Search]